Average Co-Inventor Count = 7.96
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Bayer Schering Pharma Ag (6 from 192 patents)
2. Schering Aktiengesellschaft (4 from 1,384 patents)
3. Zentaris Ag (2 from 20 patents)
4. Bayer Intellectual Property Gmbh (1 from 721 patents)
5. Bayer Pharma Aktiengesellschaft (378 patents)
13 patents:
1. 8796253 - Heteroaryl substituted pyrazole derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
2. 7906533 - Nicotinamide pyridinureas as vascular endothelial growth factor (VEGF) receptor kinase inhibitors
3. 7902229 - Anthranilamide pyridinureas as vascular endothelial growth factor (VEGF) receptor kinase inhibitors
4. 7615565 - VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridines
5. 7605136 - Effector conjugates, methods for their preparation and their pharmaceutical use
6. 7572794 - Anthranilamide pyridinureas as vascular endothelial growth factor (VEGF) receptor kinase inhibitors
7. 7517894 - VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridines
8. 7511059 - Thiazolidinones, their production and use as pharmaceutical agents
9. 7378522 - Quinoline, isoquinoline and phthalazine derivatives as antagonists of the gonadotropin-releasing hormone
10. 7202260 - VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridones
11. 7148357 - VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridines
12. 6790858 - Quinoline, isoquinoline and phthalazine derivatives as antagonists of the gonadotropin-releasing hormone
13. 6780594 - Method for in vitro diagnosis of endometriosis